Muscle Wasting Disorders Market to be Propelled by Surge in Prevalence of Chronic Diseases and a Rise in the Geriatric Population Globally
Sarcopenia is the progressive loss of skeletal muscle, which takes place with aging. Most individuals begin to lose muscle mass after the age of thirty. Sarcopenia affects approximately 30% of individuals who are above the age of sixty and more than 50% of individuals above eighty years of age. The weakness associated with sarcopenia dramatically increases the risk of accidents due to falls in older adults.
Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39452
It has been reported that nearly half of all accidental deaths among individuals over sixty-five years is due to falls. Other metabolic conditions such as insulin resistance, type 2 diabetes, and obesity can also give rise to sarcopenia. The health care expenditure on sarcopenia stands at approximately US$ 900 per person in a year. Thus, a rise in awareness about sarcopenia and related disorders is expected to drive demand for muscle wasting disorder therapeutics during the forecast period.
Increase in research & development activities by leading pharmaceutical companies, surge in prevalence of chronic diseases such as cancer and spinal muscular atrophy, and a rise in the geriatric population globally are major factors propelling the muscle wasting disorders market. Moreover, increased government funding for research and rise in cancer awareness programs and patient support programs in developing countries are anticipated to boost the muscle wasting disorders market in the near future.
A number of drugs in the pipeline for the treatment of spinal muscular atrophy have received orphan drug designation in the U.S. as well as Europe due to strong government support. This is projected to help the spinal muscular atrophy market expand rapidly, while encouraging pharmaceutical companies to invest in the development of novel therapeutics for the treatment of SMA. However, stringent regulatory requirements and high cost of drug development are anticipated to restrain the market.
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=39452
The global muscle wasting disorders market can be segmented based on treatment type, disease indication, end-user, and geography. In terms of treatment type, the global muscle wasting disorders market can be classified into drug treatment, surgical method, and other treatments. Promising clinical pipeline and upcoming regulatory approvals are the major factors contributing to a rapid expansionof the drug treatment segment. For instance, several drugs for cancer cachexia that are currently under clinical trial have shown promising effects. These drugs include ghrelin mimetics, selective cox-2 inhibitors, thalidomide, insulin, olanzapine, and oxandrolone.
Based on disease indication, the global muscle wasting disorders market can be divided into cancer, chronic heart failure, kidney disease, sarcopenia, and others. The cancer disease indication segment is anticipated to constitute a major share of the market in the near future due to the rise in incidence of cancer worldwide. Rise in cancer-afflicted population is anticipated to be one of the key drivers of the muscle wasting disorders market.
According to a Centers for Disease Control and Prevention (CDC) report in 2014, the number of cancer patients diagnosed in the U.S. stood at approximately twenty-one million. This number is expected to reach 25.4 million by the end of 2024. Moreover, the National Cancer Institute also states that approximately 20% to 40% of cancer patients die due to cachexia.
Based on geography, the global muscle wasting disorders market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Established industrial infrastructure and increase in product development of muscle wasting drugs across verticals are likely to propel the muscle wasting disorders market in North America during the forecast period.
Moreover, increase in demand for early diagnosis and rise in government regulations for quality assurance and efficacy of muscle wasting disorders drugs are anticipated to boost the market. The muscle wasting disorders market in Asia Pacific is estimated to expand at a rapid pace during the forecast period owing to a rise in the geriatric population, large patient pool, increase in concerns regarding basic health care, and rise in infrastructure standards in the region.
Obtain Report Details @ https://www.transparencymarketresearch.com/muscle-wasting-disorders-market.html
Some of the major players in the global muscle wasting disorders market are Biogen, Pfizer, BioMarin Pharmaceutical Inc, Cellular Biomedicine Group, Inc., Ionis Pharmaceuticals, Marathon Pharmaceuticals LLC, Mitsubishi Tanabe Pharma, Morphosys AG, Novartis AG, Sarepta Therapeutics, and Teijin Pharma.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Muscle Wasting Disorders Market to be Propelled by Surge in Prevalence of Chronic Diseases and a Rise in the Geriatric Population Globally here
News-ID: 988018 • Views: 115
More Releases from Transparency Market Research
Electrical Submersible Pumps Market is projected to reach US$16.75 bn by the end …
An enormous number of unmistakable undertakings with solid brands right now speak to the greater part in the global electrical submersible pumps (ESPs) market. This furnishes the market with a profoundly focused seller scene. As indicated by Transparency Market Research (TMR), the main four organizations working in the market, containing Schlumberger Limited, Borets Company, LLC, Baker Hughes Incorporated, and GE Oil and Gas, held over 86% of the worldwide ESP
Circulating Fluidized Bed Boilers Market 2023 - Opportunities And Challenges
Innovation varieties, the ongoing advances in plan, and divided assembling have brought about a high level of rivalry in the global circulating fluidized bed (CFB) boilers advertise. This thusly has constrained the main endeavors in the market, for example, Alfa Laval AB, AE&E Nanjing Boiler Co. Ltd., Bharat Heavy Electricals Limited (BHEL), and others to concentrate on direct advertising. According to Transparency Market Research (TMR), most of these organizations as
Power Transmission Towers and Cables Market 2023 : Forecasts, Technologies, Play …
The global power transmission towers and cables market features an exceptionally divided and a particularly unique working condition, discovers Transparency Market Research (TMR). A portion of the main merchants in the market are Kalpataru Power Transmission Ltd., Zhejiang Shengda Steel Tower Co., Ltd., Nanjing Daji Iron Tower Manufacturing Co. Ltd., ShanDong DingChang Tower Co., Ltd., KEC International, Ltd., and Sumitomo Electric Industries, Ltd. Countless players working in this divided landscape
Crude Oil Carriers Market is projected to reach US$217 Bn by 2023
Transparency Market Research has released a new market report titled " Crude Oil Carriers Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast 2016 - 2024." According to this report, the global crude oil carriers market was valued at US$160 Bn in 2015 and is projected to reach US$217 Bn by 2023 at a CAGR of 3.5% from 2016 to 2024. View Complete Report @ https://www.transparencymarketresearch.com/crude-oil-carriers-market.html Crude oil
More Releases for Muscle
Muscle Stimulation Devices Market: Global Forecast over 2018 to 2028
Application of Novel Nerve Stimulation Device to Offer New Dimension to Stroke Care, Improving Overall Quality of Life The performance of the global muscle stimulation devices market is expected to witness immensely impactful developments, with potential improvements in the recovery of stroke through nerve stimulation. With rising rate of AIS (acute ischemic stroke), the focus has been shifted to improving the associated stages of stroke care, including prevention, intervention, and rehabilitation.
Muscle Spasm Market to Record Sturdy Growth by 2020
Muscle spasm is involuntary, sudden contraction of muscle or group of muscles of the body. Muscle spasm is also known as muscle cramp or involuntary hypertonicity. Muscle spasm usually occurs after muscular injury and is a sudden blast of high intensity pain, which ceases after five to ten minutes. Muscle spasm, in general condition, does not cause any chronic harm to the body. The most commonly affected muscles are lower
Muscle Stimulator Market expands the frontiers of medical research
Electrical muscle stimulators are used for a variety of purposes in physical therapy. The main aim of muscle stimulators is to improve blood circulation, improve muscle control, toning of the muscles and increase in the muscle strength. This is achieved by imparting electrical current to the body, making the muscles contract. An electronic device is used to send electric current to a specific area in the body through a series
Europe Muscle Stimulation Devices Market Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "Europe Muscle Stimulation Devices Market Report 2017" Description This report studies sales (consumption) of Muscle Stimulation Devices in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering DJO Global Zynex NeuroMetrix RS Medical Omron Market Segment by Countries, this report splits Europe into several key Countries, with
Muscle Beach® Transitions to Product Licensing
Muscle Beach®, the iconic fitness brand that single-handedly jumpstarted the fitness revolution, will now be licensing its name exclusively to retailers and manufacturers, and is in the process of phasing out its current club licensing program. South Hadley, MA, January 12, 2012 -- Muscle Beach®, the iconic fitness brand that single-handedly jumpstarted the fitness revolution, will now be licensing its name exclusively to retailers and manufacturers, and is in the process
Muscle Beach® Comes to the Carolinas
Muscle Beach®, the iconic fitness brand that single-handedly jumpstarted the fitness revolution, has converted a former Nautilus Fitness Center in Orangeburg South Carolina to their prestigious brand. Wilbraham, MA, July 19, 2011 -- Muscle Beach®, the iconic fitness brand that single-handedly jumpstarted the fitness revolution, has converted a former Nautilus Fitness Center in Orangeburg South Carolina to their prestigious brand. “As the entity that led to the establishment of Gold's Gym® and